NBP

Conviction 0HealthcareScan · Mon, Aug 10, 2026

Three white soldiers

NBP$1.77+1.14%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 229.78K

May 11May 28Jun 16Jul 6Jul 23Aug 10

NovaBridge BiosciencesBiotechnologywww.novabridge.com ↗

Price1.77

Change+1.14%

Gap-0.29%

Rel volume0.79×

Avg volume242.49K

Avg $ vol421.47K

SMA 201.73

SMA 501.73

SMA 200—

Price vs 50+2.45%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 1.91

RSI (14)53

MACD hist0.01

MACD crossbull · 0d

Stoch %K / %D66 / 54

ADX (14)13

+DI / −DI27 / 19

RSI divergence—

MACD divergence—

ATR %+5.61%

ADR %4.92%

52w high4.95

52w low1.47

From 52w high-64.24%

Above 52w low+20.41%

New 52w highNo

SqueezeOn · 1d

Bollinger width17.63%

%B0.63

Donchian pos59.38%

Donchian high1.90

Donchian low1.58

AVWAP (52w high)2.64

vs AVWAP high-32.88%

AVWAP (52w low)1.82

vs AVWAP low-2.96%

OBV trendFlat

Chaikin MF (20)-0.01

Today vs 20d0.79×

Avg vol (14d)229.78K

Avg vol (20d)242.49K

Avg $ vol (20d)421.47K

Market cap469.72M

RS 3m (vs SPY)-26.87%

RS 6m (vs SPY)-61.56%

RS line new highNo

Trend template—

Technical rank28.7

1 week+9.94%

1 month-6.84%

3 months-19.55%

6 months-52.16%

1 year—

YTD-58.55%

P/E—

P/B2.03

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.02

Current8.09

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value263.31M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out115.65M

Employees30

ListedFri, Jan 17, 2020

Free float64.21M

Float %55.5%

Short interest4.33M

Days to cover6.1d

Short volume58.2%

Squeeze score51 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank28.7 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree white soldiers

News sentiment—

Congress activity

Disclosed STOCK Act trades in NBP

All disclosures →

No recent disclosed trades by Congress in NBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NBP · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Hagler Mark Arnold Chief Commercial Officer · 2025 Employee Share Option (right to buy) · 2026-07-08	Grant	949.05K	—	2026-07-08	2026-07-10
Lin Liwei Lorraine General Counsel · 2025 Employee Share Option (right to buy) · 2026-07-08	Grant	254.78K	—	2026-07-08	2026-07-10
Gupta Srishti Chief Executive Officer · 2025 Employee Share Option (right to buy) · 2026-07-06	Grant	3M	—	2026-07-06	2026-07-08
Xu Cong Claire SVP, Clinical Development · Ordinary Shares · 2026-07-06	Sell	4.49K	$4K	2026-07-06	2026-07-07
Xu Cong Claire SVP, Clinical Development · Ordinary Shares · 2026-07-04	Exercise	12.43K	—	2026-07-04	2026-07-07
Xu Cong Claire SVP, Clinical Development · Restricted Share Units · 2026-07-04	Exercise	5.41K	—	2026-07-04	2026-07-07
Fu Wei Director · 2025 Employee Share Option (right to buy) · 2026-06-29	Grant	725.14K	—	2026-06-29	2026-06-30
Fu Wei Director · 2025 Employee Share Option (right to buy) · 2026-06-29	Grant	1.09M	—	2026-06-29	2026-06-30
Fu Wei Director · Restricted Share Units · 2026-06-29	Grant	1.01M	—	2026-06-29	2026-06-30
Cao Sean Wuxiong Chief Bus. Development Officer · Restricted Share Units · 2026-06-22	Grant	181.28K	—	2026-06-22	2026-06-24

SEC filings

EDGAR filings in NBP · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.